Uterine artery doppler in first-trimester pregnancy screening

Clinical Obstetrics and Gynecology

Volumn 53, Issue 4, 2010, Pages 879-887

  Bahado Singh, Ray O ^a   Jodicke, Cristiano ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

IUGR; preeclampsia; uterine artery Doppler

Indexed keywords

BIOCHEMICAL MARKER; INHIBIN A; PLACENTA PROTEIN; PLACENTA PROTEIN 13; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; LASER DOPPLER FLOWMETRY; PLACENTA CIRCULATION; PREDICTION; PREECLAMPSIA; PRENATAL SCREENING; PROPHYLAXIS; REVIEW; UTERINE ARTERY; VASCULARIZATION;

BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; FEMALE; FETAL GROWTH RETARDATION; GALECTINS; HUMANS; INFANT; INHIBINS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY;

EID: 78349250199     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3181fbb65d     Document Type: Review

References (18)

1. Kaufmann P, Black S, Huppertz B. Endo-vascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69:1-7.
2. Poon LC, Karagiannis G, Leal A, et al. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks. Ultrasound Obstet Gynecol. 2009;34:497-502.
3. Plasencia W, Maiz N, Poon L, et al. Uterine artery Doppler at 11+0 to 13+6 weeks and 21+0 to 24+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet.Gynecol. 2008;32:138-146.
4. Melchiorre K, Wormald B, Leslie K, et al. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet.Gynecol. 2008;32:133-137.
5. Erez O, Romero R, Espinoza J, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008;21:279-287.
6. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gesta-tional age neonate. J Matern Fetal Neonatal Med. 2008;21:9-23.
7. Martin AM, Bindra R, Curcio P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Dop-pler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18:583-586.
8. Gomez O,Mart?nezJM, FiguerasF,et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol. 2005;26:490-494.
9. Akolekar R, Minekawa R, Veduta A, et al. Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009;29: 753-760.
10. Nicolaides KH, Bindra R, Turan OM, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet.Gynecol. 2006;27:13-17.
11. Tidwell SC, Ho HN, Chiu WH, etal. Low maternal serum levels of placenta growth factor as an antecedent of clinical pre-eclampsia. Am J Obstet Gynecol. 2001;184:1267-1272.
12. Dugoff L, Lynch AM, Cioffi-Ragan D, et al. First trimester uterine artery Doppler abnormalities predict subsequent intrau-terine growth restriction. Am J Obstet Gynecol. 2005;193:1208-1212.
13. Melchiorre K, Leslie K, Prefumo F, et al. First-trimester uterine artery Doppler indices in the prediction of small-for-gesta-tional age pregnancy and intrauterine growth restriction. Ultrasound Obstet Gy-necol. 2009;33:524-529.
14. Akolekar R, Zaragoza E, Poon LC, et al. Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:732-739.
15. Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasono-graphy to predict pre-eclampsia and in-trauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178:701-711.
16. Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2:CD004659.
17. Vainio M, Riutta A, Koivisto AM, et al. Prostocyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. Acta Obstet Gynecol Scand. 2004;83: 1119-1123.
18. Askie LM, Duley L, Henderson- Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369: 1791-1798.